Status:
COMPLETED
SGLT-i Use in Diabetic Foot Ulcer Disease
Lead Sponsor:
University of Leicester
Conditions:
Diabetic Foot Ulcer
Eligibility:
All Genders
18+ years
Brief Summary
Background: People with diabetes and either current or previous diabetic foot ulcer disease (DFUD) are at very high risk for adverse cardiovascular events including heart attacks and strokes. Sodium-g...
Eligibility Criteria
Inclusion
- Participants who are trained healthcare practitioners involved in the care of patients with current or previous diabetic foot ulcer disease
Exclusion
- Potential participants who do not give informed consent. Potential participants who will not be able to participate in both rounds of the Delphi process.
Key Trial Info
Start Date :
December 5 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2024
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT06000722
Start Date
December 5 2023
End Date
April 30 2024
Last Update
May 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Leicester
Leicester, United Kingdom